Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5)

NCT00523211 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

506

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections
Acquired Immunodeficiency Syndrome

Interventions

DRUG: Vicriviroc
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC